An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

New England Journal of Medicine, Ahead of Print.

Source: New England Journal of Medicine - June 8, 2019 Category: Internal Medicine Authors: Kevan C. Herold Brian N. Bundy S. Alice Long Jeffrey A. Bluestone Linda A. DiMeglio Matthew J. Dufort Stephen E. Gitelman Peter A. Gottlieb Jeffrey P. Krischer Peter S. Linsley Jennifer B. Marks Wayne Moore Antoinette Moran Henry Rodriguez William E. Russ Source Type: research